the Public Financing Of Pharmaceuticals: An Economic Approach

استعرض الموضوع السابق استعرض الموضوع التالي اذهب الى الأسفل

the Public Financing Of Pharmaceuticals: An Economic Approach

مُساهمة من طرف زائر في السبت 3 أكتوبر - 4:57

the Public Financing Of Pharmaceuticals: An Economic Approach











The Public Financing Of Pharmaceuticals: An Economic Approach






By




Publisher: Edward Elgar Publishing


Number Of Pages: 255


Publication Date: 2005-04-05


Sales Rank: 2139278


ISBN / ASIN: 1845420888


EAN: 9781845420888


Binding: Hardcover


Manufacturer: Edward Elgar Publishing


Studio: Edward Elgar Publishing


Average Rating: 0


Total Reviews: 0










Book Description:








This book provides a complete approach to the economics of financing
medicines and policy implications for the efficiency and equity of
health systems. In all health systems with majority public financing,
pharmaceutical reimbursement is one of the key factors in policies of
change and transformation of health services in order to face the
future with guarantees of financial sustainability.


The initial chapters seek to answer questions about the efficiency with
which the public sector intervenes in the pharmaceutical industry: Is
the present system of drug patents efficient and fair? What would be
the best way to control drug prices? Is it possible to encourage
competition in this market for the patient's benefit? The remainder of
the book provides evidence on the impact of instruments and policies
aimed at rationalizing and controlling pharmaceutical expenditure: What
can we expect from the application of reference pricing systems? When,
how and where should the user be made to share the cost of medicines?
What economic and non-economic incentives should be applied to drug
prescription?


Jaume Puig-Junoy has performed an invaluable task in creating a
cohesive, and analytically rigorous book of specially commissioned
chapters on this pertinent topic.


The Public Financing of Pharmaceuticals will appeal to academics and
researchers involved in public finance, health policy, health
economics, industrial organization and the pharmaceutical markets in
Europe and in the US, where there is increasing public interest in drug
coverage. The book is also intended for a wide variety of professionals
in the health industries and policymakers.








rapidshare.com 93.rar

زائر
زائر


الرجوع الى أعلى الصفحة اذهب الى الأسفل

استعرض الموضوع السابق استعرض الموضوع التالي الرجوع الى أعلى الصفحة

- مواضيع مماثلة

 
صلاحيات هذا المنتدى:
لاتستطيع الرد على المواضيع في هذا المنتدى